Janney Montgomery Scott
TAK icon

Janney Montgomery Scott’s Takeda Pharmaceutical TAK Stock Holding History

Janney Montgomery Scott’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,002
Closed -$156K – 3035
2025
Q4 		$156K Buy
+10,002
New +$143K ﹤0.01% 2834
2024
Q4 		– Sell
-13,310
Closed -$189K – 2842
2024
Q3 		$189K Sell
13,310
-2,001
-13% -$28.4K ﹤0.01% 2526
2024
Q2 		$198K Sell
15,311
-4,364
-22% -$57.8K ﹤0.01% 2457
2024
Q1 		$273K Sell
19,675
-7,385
-27% -$107K ﹤0.01% 2395
2023
Q4 		$386K Sell
27,060
-8,797
-25% -$125K ﹤0.01% 2079
2023
Q3 		$555K Sell
35,857
-20,228
-36% -$313K ﹤0.01% 1702
2023
Q2 		$881K Sell
56,085
-14,328
-20% -$235K ﹤0.01% 1495
2023
Q1 		$1.16M Sell
70,413
-2,319
-3% -$36.9K ﹤0.01% 1242
2022
Q4 		$1.14M Sell
72,732
-37,833
-34% -$528K ﹤0.01% 1297
2022
Q3 		$1.43M Sell
110,565
-1,938
-2% -$26.9K 0.01% 1137
2022
Q2 		$1.56M Buy
112,503
+78,779
+234% +$1.12M 0.01% 1041
2022
Q1 		$483K Buy
+33,724
New +$495K ﹤0.01% 1629
2021
Q4 		– Sell
-12,046
Closed -$197K – 2426
2021
Q3 		$197K Buy
+12,046
New +$202K ﹤0.01% 2168

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Janney Montgomery Scott's TAK Position: Q1 2026 in Review

Janney Montgomery Scott sold out of Takeda Pharmaceutical (TAK) in Q1 2026, closing a stake of 10,002 shares — an estimated $156K sold.

Janney Montgomery Scott first reported a position in TAK in Q3 2021 and held it in 13 quarters. The position peaked at $1.56M in Q2 2022. 358 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

  • Janney Montgomery Scott reported no remaining Takeda Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Janney Montgomery Scott sold 10,002 Takeda Pharmaceutical shares in Q1 2026, an estimated $156K.
  • Janney Montgomery Scott first reported a position in Takeda Pharmaceutical in Q3 2021 and held it in 13 quarters.
  • Janney Montgomery Scott's Takeda Pharmaceutical position peaked at $1.56M in Q2 2022.
  • 358 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.